Table 4.
Item | CL1) | HME (ppm) | P-ZnO1) | SEM | Contrasts2) (p-value) | |||||
---|---|---|---|---|---|---|---|---|---|---|
|
|
|||||||||
500 | 1,000 | 2,500 | CL vs others | HME vs P-ZnO | L | Q | ||||
Phase I (d 14) | ||||||||||
IgG | 249 | 238 | 225 | 232 | 236 | 15.5 | 0.652 | 0.811 | 0.321 | 0192 |
IgA | 27.2 | 27.5 | 28.7 | 28.6 | 29.5 | 0.57 | 0.077 | 0.112 | 0.112 | 0526 |
IgM | 6.25 | 6.75 | 6.67 | 6.75 | 6.50 | 0.27 | 0.185 | 0.451 | 0.185 | 0.623 |
Phase II (d 28) | ||||||||||
IgG | 264 | 248 | 242 | 261 | 245 | 14.9 | 0.319 | 0.725 | 0.912 | 0.348 |
IgA | 27.9 | 28.9 | 29.7 | 28.6 | 30.2 | 0.53 | 0.087 | 0.259 | 0.522 | 0.205 |
IgM | 6.50 | 7.25 | 7.00 | 6.88 | 6.75 | 0.22 | 0.126 | 0.264 | 0.698 | 0.126 |
HME, hot melt extrusion; SEM, standard error of means; Ig, immunoglobulin.
CL, basal diet without ZnO; HME, basal diet with 500, 1,000, and 2,500 ppm Zn as HME-ZnO; P-ZnO, basal diet with 2,500 ppm Zn as ZnO.
Linear (L) and quadratic (Q) effects of HME concentrations.